Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-22 Purchase | 2024-01-24 6:44 pm | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks 10% Owner | 476,190 | $21 | $9,999,990 | 1,845,813 (Indirect) | View |
| 2023-06-15 Sale | 2023-06-20 5:23 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer | 2,296 | $28.02 | $64,343 | 104,905 (Direct) | View |
| 2023-06-02 Sale | 2023-06-06 7:41 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer | 7,500 | $24.82 | $186,136 | 221,975 (Direct) | View |
| 2023-04-12 Purchase | 2023-04-12 7:05 pm | Viridian Therapeutics Inc. | VRDN | Myers Scott Dunseth Chief Executive Officer | 4,000 | $25.37 | $101,479 | 259,500 (Direct) | View |
| 2023-03-13 Purchase | 2023-03-13 4:06 pm | Viridian Therapeutics Inc. | VRDN | Myers Scott Dunseth Chief Executive Officer | 5,500 | $29.15 | $160,324 | 255,500 (Direct) | View |
| 2023-03-09 Sale | 2023-03-10 4:05 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 29,971 | $29.07 | $871,257 | 0 (Direct) | View |
| 2023-02-02 Sale(A) | 2023-02-07 6:35 pm | Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer | 50,000 | $36.8 | $1,840,000 | 720,110 (Direct) | View |
| 2023-02-02 Sale | 2023-02-03 6:12 pm | Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer | 50,000 | $36.8 | $1,840,000 | 430,905 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 6:04 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 6,843 | $35.66 | $244,021 | 59,753 (Direct) | View |
| 2023-01-13 Sale | 2023-01-18 5:58 pm | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 29,000 | $37.18 | $1,078,261 | 558,853 (Direct) | View |
| 2023-01-09 Sale | 2023-01-11 7:09 pm | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 60,000 | $34.82 | $2,089,472 | 639,377 (Direct) | View |
| 2022-12-20 Sale | 2022-12-22 4:42 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,926 | $29.15 | $493,398 | 105,768 (Direct) | View |
| 2022-12-15 Sale | 2022-12-19 7:22 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 1,597 | $28.37 | $45,311 | 124,591 (Direct) | View |
| 2022-12-12 Sale | 2022-12-14 8:56 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,256 | $28.12 | $457,077 | 142,144 (Direct) | View |
| 2022-11-15 Sale | 2022-11-16 6:45 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 8,125 | $22.05 | $179,156 | 21,875 (Direct) | View |
| 2022-08-17 Purchase | 2022-08-19 4:32 pm | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks 10% Owner | 425,531 | $23.5 | $9,999,979 | 1,369,623 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-28 Other | 2024-04-01 6:32 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director 10% Owner | 49,857 | $0 | 1,990,722 (Indirect) | View |
| 2024-02-12 Option Award | 2024-02-14 4:05 pm | N/A 2034-02-12 | Viridian Therapeutics Inc. | VRDN | Tousignant Jennifer Chief Legal Officer | 290,000 | $0 | 290,000 (Direct) | View |
| 2024-02-05 Option Award | 2024-02-07 4:01 pm | N/A 2034-02-05 | Viridian Therapeutics Inc. | VRDN | Ciulla Thomas Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2024-01-12 4:31 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Ciulla Thomas Chief Medical Officer | 0 | $0 | 570,762 (Direct) | View |
| 2023-11-10 Option Award | 2023-11-13 5:17 pm | N/A 2033-11-10 | Viridian Therapeutics Inc. | VRDN | Harmon Seth See Remarks | 270,000 | $0 | 270,000 (Direct) | View |
| 2023-10-30 Option Award | 2023-11-01 9:05 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks 10% Owner | 48,463 | $825.37 | 48,463 (Indirect) | View |
| 2023-10-30 Option Award | 2023-11-01 4:35 pm | N/A 2023-10-30 | Viridian Therapeutics Inc. | VRDN | Beetham Thomas W. Chief Operating Officer | 474,400 | $0 | 474,400 (Direct) | View |
| 2023-10-30 Option Award | 2023-11-01 4:35 pm | N/A 2033-10-30 | Viridian Therapeutics Inc. | VRDN | Mahoney Stephen F. President and CEO | 1,259,400 | $0 | 1,259,400 (Direct) | View |
| 2023-09-21 Option Award | 2023-09-25 4:35 pm | N/A 2033-09-21 | Viridian Therapeutics Inc. | VRDN | Gheuens Sarah Director | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2023-09-19 4:30 pm | N/A 2033-06-01 | Viridian Therapeutics Inc. | VRDN | Harmon Seth See Remarks | 0 | $0 | 175,000 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-20 5:23 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer | 2,296 | $23.03 | 104,905 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-20 5:23 pm | N/A 2031-01-18 | Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer | 2,297 | $0 | 104,905 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 8:00 pm | N/A 2023-06-14 | Viridian Therapeutics Inc. | VRDN | Harwin Peter Evan Director | 20,000 | $0 | 20,000 (Indirect) | View |
| 2023-06-14 Option Award | 2023-06-16 7:54 pm | N/A 2033-06-14 | Viridian Therapeutics Inc. | VRDN | Moses Jennifer K. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 7:54 pm | N/A 2033-06-14 | Viridian Therapeutics Inc. | VRDN | Kiselak Tomas Director | 20,000 | $0 | 20,000 (Indirect) | View |
| 2023-06-14 Option Award | 2023-06-16 7:51 pm | N/A 2033-06-14 | Viridian Therapeutics Inc. | VRDN | Morris Arlene Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-06 7:41 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer | 1,875 | $14 | 221,975 (Direct) | View |
| 2023-06-05 Exercise | 2023-06-06 7:41 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer | 5,625 | $18.51 | 221,975 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-06 7:41 pm | N/A 2031-09-22 | Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer | 7,500 | $0 | 221,975 (Direct) | View |
| 2023-02-08 Option Award | 2023-02-10 4:54 pm | N/A 2033-02-08 | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 108,000 | $0 | 108,000 (Direct) | View |
| 2023-02-08 Option Award | 2023-02-10 4:51 pm | N/A 2033-02-08 | Viridian Therapeutics Inc. | VRDN | Melvin Carrie COO | 54,000 | $0 | 54,000 (Direct) | View |
| 2023-02-08 Option Award | 2023-02-10 4:49 pm | N/A 2033-02-08 | Viridian Therapeutics Inc. | VRDN | Humer Kristian CFO and CBO | 108,000 | $0 | 108,000 (Direct) | View |
| 2023-02-08 Option Award | 2023-02-10 4:47 pm | N/A 2033-02-08 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 108,000 | $0 | 108,000 (Direct) | View |
| 2023-02-06 Option Award | 2023-02-07 6:55 pm | N/A 2033-02-06 | Viridian Therapeutics Inc. | VRDN | Myers Scott Dunseth Chief Executive Officer | 1,250,000 | $0 | 1,250,000 (Direct) | View |
| 2023-02-02 Exercise(A) | 2023-02-07 6:35 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer | 50,000 | $0.15 | 720,110 (Direct) | View |
| 2023-02-02 Exercise(A) | 2023-02-07 6:35 pm | N/A 2030-09-23 | Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer | 50,000 | $0 | 720,110 (Direct) | View |
| 2023-01-23 Exercise | 2023-01-25 6:04 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 1,872 | $14 | 59,753 (Direct) | View |
| 2023-01-23 Exercise | 2023-01-25 6:04 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 4,971 | $23.03 | 59,753 (Direct) | View |
| 2023-01-23 Exercise | 2023-01-25 6:04 pm | N/A 2031-01-18 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 6,843 | $0 | 59,753 (Direct) | View |
| 2023-01-13 Exercise | 2023-01-18 5:58 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 29,000 | $23.03 | 558,853 (Direct) | View |
| 2023-01-13 Exercise | 2023-01-18 5:58 pm | N/A 2031-01-17 | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 29,000 | $0 | 558,853 (Direct) | View |
| 2023-01-09 Exercise | 2023-01-11 7:09 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 60,000 | $23.03 | 639,377 (Direct) | View |
| 2023-01-09 Exercise | 2023-01-11 7:09 pm | N/A 2031-01-17 | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 60,000 | $0 | 639,377 (Direct) | View |
| 2022-12-20 Exercise | 2022-12-22 4:42 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,926 | $23.03 | 105,768 (Direct) | View |
| 2022-12-20 Exercise | 2022-12-22 4:42 pm | N/A 2031-09-22 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,926 | $0 | 105,768 (Direct) | View |
| 2022-12-15 Exercise | 2022-12-19 7:22 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 1,597 | $23.03 | 124,591 (Direct) | View |
| 2022-12-15 Exercise | 2022-12-19 7:22 pm | N/A 2031-09-22 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 1,597 | $0 | 124,591 (Direct) | View |
| 2022-12-12 Exercise | 2022-12-14 8:56 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,256 | $23.03 | 142,144 (Direct) | View |
| 2022-12-12 Exercise | 2022-12-14 8:56 pm | N/A 2031-09-22 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,256 | $0 | 142,144 (Direct) | View |
| 2022-11-15 Exercise | 2022-11-16 6:45 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 8,125 | $14 | 21,875 (Direct) | View |
| 2022-11-15 Exercise | 2022-11-16 6:45 pm | N/A 2031-09-22 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 8,125 | $0 | 21,875 (Direct) | View |